In view of her confirmation as EU Commission President, biotech associations have reminded Ursula von der Leyen of her promise to strategically promote the sector with an EU Biotech Act 2025.
https://european-biotechnology.com/wp-content/uploads/2024/07/von-der-Leyen-EB.jpg12001800Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2024-07-21 13:16:442024-09-19 15:01:31Von der Leyen: no mention of biotechnology
Scientists at Hannover Medical School (MHH) have genetically engineered pig lungs in such a way that immunosuppressants could be reduced during transplants.
https://european-biotechnology.com/wp-content/uploads/2024/07/Draupnir-Bio-.png11681746Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2024-07-17 11:15:572024-07-22 11:31:00Draupnir Bio ApS raises further equity
CordenPharma is making a record investment of about €900m over the next three years in expanding its peptide platform, both at its Colorado, US site and in Europe.
In the largest expansion in the company’s 150-year history, the Laupheim-headquartered CDMO Rentschler Biopharma SE has launched a new production line at its site in Milford, USA.
German iRhom2-targeted antibody specialist SciRhom GmbH has closed an oversubscribed €63m Series A financing that will be used to provide clinical proof of concept in autoimmune disorders.
Von der Leyen: no mention of biotechnology
Latest NewsIn view of her confirmation as EU Commission President, biotech associations have reminded Ursula von der Leyen of her promise to strategically promote the sector with an EU Biotech Act 2025.
Scientists prevent transplant rejection
Latest NewsScientists at Hannover Medical School (MHH) have genetically engineered pig lungs in such a way that immunosuppressants could be reduced during transplants.
New Chief Scientific Officer
AppointmentsCambridge-based Mogrify Ltd announces the appointment of Dr. Jonathan Appleby as Chief Scientific Officer.
SOTIO partners with Biocytogen to expand ADC pipeline
Latest NewsCzech Sotio Biotech has inked an R&D and licence option agreement with Chinese antibody maker Biocytogen.
Draupnir Bio ApS raises further equity
Latest NewsTargeted protein degradation Draupnir Bio Aps has raised further €12m in an equitiy investment to advance its preclinical pipeline.
CordenPharma invests €900m in peptide patform expansion
Latest NewsCordenPharma is making a record investment of about €900m over the next three years in expanding its peptide platform, both at its Colorado, US site and in Europe.
Catalym raises US$150m
Latest NewsGerman cancer specialist Catalym GmbH has raised US$150m to finance proof-of-concept studies.
Sensorion achieves milestones in Phase II trial
Latest NewsFrench Sensorion SA has reported new efficacy endpoints data from SENS-401 in a Phase II study for the preservation of residual hearing loss.
Rentschler doubles cGMP capacity
Latest NewsIn the largest expansion in the company’s 150-year history, the Laupheim-headquartered CDMO Rentschler Biopharma SE has launched a new production line at its site in Milford, USA.
SciRhom GmbH closes €63m Series A financing
Latest NewsGerman iRhom2-targeted antibody specialist SciRhom GmbH has closed an oversubscribed €63m Series A financing that will be used to provide clinical proof of concept in autoimmune disorders.